# Gladius Therapeutics, Inc. — Form D

Gladius Therapeutics, Inc. of PHILADELPHIA, PA, a company, filed a Form D exempt-offering notice with the SEC on 2023-08-22. The offering totals $300K, of which $300K was reported sold. Industry: Other Health Care.

## Offering

- Filed: 2023-08-22
- Form: D
- Accession: 0001986426-23-000001
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $300K
- Amount sold: $300K
- Investors: 4
- Date of first sale: 2023-08-14
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-490377

## Issuer

- Name: Gladius Therapeutics, Inc.
- CIK: 0001986426
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2023
- Address: B+LABS, FLOOR 2, PHILADELPHIA, PA, 19104
- Phone: 215-518-3590

## Officers, directors & promoters (3)

| Name | Role | Location |
| --- | --- | --- |
| Michael Seiden | Director | Raleigh, NC |
| Michael Seiden | Executive Officer | Raleigh, NC |
| Michael Seiden | Promoter | Raleigh, NC |

## More

- [CIK 1986426 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1986426&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001986426-23-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.